EU HTA Regulation: ‘Another Layer Of Bureaucracy For Medtech To Overcome’
MedTech Europe is “highly skeptical” about the added value of the forthcoming EU Regulation on Health Technology Assessment for health systems and citizens and explained to Medtech Insight how it currently fails medtech.
You may also be interested in...
After three and a half years of negotiations, the EU is on the point of formalizing its agreement on closer collaboration between member states on health technology assessment.
The regulation of companion diagnostics will be far stricter under the IVDR than the current IVD Regulation. EU life sciences regulatory lawyer Elisabethann Wright provides an overview and explains how companies should prepare for compliance.
Due to a lack of clarity in the MDR wording around which devices should be accompanied by implant cards, there is a risk companies may not supply them when patients would benefit. TEAM-NB offers guidance.